Filing Details
- Accession Number:
- 0001022079-22-000127
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-02 16:25:48
- Reporting Period:
- 2022-08-01
- Accepted Time:
- 2022-08-02 16:25:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204666 | M Timothy Ring | 500 Plaza Drive Secaucus NJ 07094 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-01 | 149 | $56.25 | 24,082 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-08-01 | 1,851 | $61.23 | 25,933 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-01 | 2,000 | $136.04 | 23,933 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2022-08-01 | 149 | $56.25 | 149 | $56.25 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2022-08-01 | 1,851 | $61.23 | 1,851 | $61.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-04-01 | 2023-04-01 | No | 4 | M | Direct |
| 4,260 | 2023-05-21 | No | 4 | M | Direct |
Footnotes
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 1, 2022.
- The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.
Billionaire Hedge Funds
